Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ryan Tarantola (NPI 1316094139)

Field	Value
Entity Type	Individual
Organization	Ryan Tarantola
Address	5150 N Davis Hwy
City	Pensacola
State	FL
ZIP	32503
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	January 4, 2007

Payer Source	Total Paid
Medicare	$5.5M
Medicaid	$0

Key Findings

This provider is heavily focused on intravitreal biologic injections and retina diagnostics: J0178 (aflibercept), J2778 (ranibizumab), and J2777 (faricimab) together account for 84.6% of lifetime Medicare revenue, and the largest single CPT/HCPCS entry is J0178 with $3.2M in revenue. The code mix (high-volume anti-VEGF and related intravitreal drug codes alongside retinal imaging 92134 and injection procedure 67028) indicates a practice model centered on medical retina services and frequent intraocular injections rather than primarily refractive or general ophthalmology care.

Revenue is highly concentrated in a very small set of drugs: the precomputed top-3 codes contribute 84.6% of Medicare revenue, with J0178 alone representing 59.2% of the provider’s total Medicare receipts. This concentration implies financial exposure to utilization changes, reimbursement shifts, or drug mix substitution affecting those specific intravitreal agents.

The provider’s Medicare footprint is large while Medicaid activity is effectively zero: lifetime Medicare revenue is $5.5M and there is no Medicaid billing on file. This makes the provider functionally single-payer (Medicare-dominated) in the available claims data, which affects payer-contracting leverage and network planning assumptions.

National competitive standing is exceptionally strong on several high-value items: the provider ranks in the 99th percentile and is labeled an "extreme outlier" for J0178 (rank #33 of 3204) and is also an extreme outlier for 92014, 92012, and 92134, indicating far above-typical national volumes for both drug administration and key ophthalmic evaluation/imaging codes. These rankings point to a major national-level presence for retina injection volume and retinal imaging among peers.

Several procedure codes show notable above-typical volume even beyond drug injections: 67028 (injection into the vitreous chamber) is described as "notably above typical national volume" and 92002 ranks very highly (99th percentile) for intermediate new-patient ophthalmology evaluations. Together these data suggest a high throughput clinic that performs many injection visits and frequent new/established eye evaluations.

Although device/surgical retina procedures appear in the portfolio, surgical volumes are modest: pars plana vitrectomy and related surgical codes such as 67042 and 67036 have low claim counts and rank in lower percentiles (36th and 7th percentiles respectively), indicating the provider’s activity is predominantly medical retina/injections rather than vitreoretinal surgery.

Tenure in the Medicare program is long: the NPI was enumerated on 2007-01-04 (~19 years ago), supporting that the high-volume injection practice is an established operation with a sustained Medicare presence rather than a recent entrant.

There is limited utilization of low-cost compounded and alternative intravitreal agents: J7999 and J9035 (compounded drug and bevacizumab) together account for a very small share of revenue (each at 0.3% and 0.1% respectively), reinforcing reliance on branded intravitreal biologics (notably aflibercept and ranibizumab) as the practice’s primary revenue drivers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	4,720	$690	$3.2M
J2778	Injection, ranibizumab, 0.1 mg	4,610	$180	$835K
J2777	Injection, faricimab‑svoa, 0.1 mg	19,200	$30	$556.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,250	$90	$289.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,990	$90	$168.9K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,930	$60	$117.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,950	$30	$114.5K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	240	$120	$28.8K
J7999	Compounded drug, not otherwise classified	240	$70	$15.7K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$870	$14.7K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

Ryan Tarantola — 7 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	5	250	800	$690	$817.6K
J2777	51	170	12,810	$30	$549.2K
J2778	5	110	660	$180	$234.1K
J2781	47	50	500	$120	$102K
67028	13	300	710	$90	$91.1K
67042	46	80	20	$1,180	$36.5K
67036	60	70	20	$1,050	$31.4K
92014	28	2,180	160	$80	$28.5K
67108	39	60	20	$1,200	$27.5K
92012	10	1,170	110	$60	$16.7K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ryan Tarantola, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sunil Gupta	FL	Retina Specialist (Ophthalmology) Physician	$11.4M	$36.1K
John Myers	FL	Retina Specialist (Ophthalmology) Physician	$5.4M	$0
Ahmet Ozkok	FL	Ophthalmology Physician	$2.1M	$193.6K
Magdalena Shuler	FL	Retina Specialist (Ophthalmology) Physician	$2M	$0
Sean Allison	MS	Retina Specialist (Ophthalmology) Physician	$1.7M	$33.4K
Anne Baranano	MS	Retina Specialist (Ophthalmology) Physician	$1.7M	$530
George Peters	MA	Ophthalmology Physician	$1.6M	$0
Shalesh Kaushal	FL	Ophthalmology Physician	$546.1K	$2.4K

Nearby Providers

Other providers in the same ZIP code as Ryan Tarantola, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baptist Health Care, Inc	FL	General Acute Care Hospital	$0	$18.4M
Interventional Therapeutics Institute, LLC	FL	Ambulatory Surgical Clinic/Center	$2.8M	$7.6K
Coyt Rountree	FL	Radiation Oncology Physician	$2.5M	$0
Rami Owera	FL	Medical Oncology Physician	$2.3M	$0
Jamal Joudeh	FL	Medical Oncology Physician	$2.1M	$0
Endoscopy Group LLC	FL	Ambulatory Surgical Clinic/Center	$1.6M	$253.9K
The Surgery Center At Woodlands, LLC	FL	Ambulatory Surgical Clinic/Center	$1.8M	$0
Shailesh Patel	FL	Medical Oncology Physician	$1.6M	$0
John Schaub	FL	Medical Oncology Physician	$1.6M	$0
Vivid Pathology PA	FL	Anatomic Pathology & Clinical Pathology Physician	$877.8K	$591K

Ryan Tarantola — Billing Profile & Reimbursement Data

Sign up for Ryan Tarantola — Billing Profile & Reimbursement Data policy alerts

Ryan Tarantola — Billing Profile & Reimbursement Data

Sign up for Ryan Tarantola — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References